Keywords: open-label, study, cop-1, ms, results, teva, pharmaceutical

OPEN-LABEL STUDY OF COP-1 IN MS

Article | 08 November 1993

Print This

The results of an open-label study of Teva Pharmaceutical Industries' copolymer-1 have been presented at the European Conference on Treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in